Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus Infection

Abstract   Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in infants and young children worldwide. Here we evaluated host demographic and viral factors associated with RSV disease severity in 325 RSV-infected infants under 1 year of age from 3 European countries during...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 226; no. Supplement_1; pp. S45 - S54
Main Authors McGinley, Joseph P, Lin, Gu Lung, Öner, Deniz, Golubchik, Tanya, O’Connor, Daniel, Snape, Matthew D, Gruselle, Olivier, Langedijk, Annefleur C, Wildenbeest, Joanne, Openshaw, Peter, Nair, Harish, Aerssens, Jeroen, Bont, Louis, Martinón-Torres, Federico, Drysdale, Simon B, Pollard, Andrew J
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 12.08.2022
Subjects
Online AccessGet full text
ISSN0022-1899
1537-6613
1537-6613
DOI10.1093/infdis/jiac163

Cover

More Information
Summary:Abstract   Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in infants and young children worldwide. Here we evaluated host demographic and viral factors associated with RSV disease severity in 325 RSV-infected infants under 1 year of age from 3 European countries during 2017–2020. Younger infants had a higher clinical severity (ReSViNET) score and were more likely to require hospitalization, intensive care, respiratory support, and/or mechanical ventilation than older infants (<3 months vs 3 to <6 months and 3 to <6 months vs ≥6 months). Older age (≥6 months vs <3 months), higher viral load, and RSV-A were associated with a greater probability of fever. RSV-A and RSV-B caused similar disease severity and had similar viral dynamics. Infants with a more severe RSV infection, demonstrated by having a higher ReSViNET score, fever, and requiring hospitalization and intensive care, were more likely to have developed subsequent wheezing at 1 year of age. Clinical Trials Registration NCT03756766.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0022-1899
1537-6613
1537-6613
DOI:10.1093/infdis/jiac163